Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PGNY · against 351 other Healthcare companies of similar size
Ranked #122 of 352 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score45 peers with a growth score of 60–69, including PGNY · Click a bar to see the companies
Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | PGNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 352 reported | 5.5% | 6.9% | 46% | 33% | |
| Earnings per share growthHigher is better · 202 reported | 65.9% | 9.9% | 78% | 33% | |
| 3-year revenue growthHigher is better · 344 reported | 11.0% | 8.2% | 58% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 122 | 2.5B USD | 67 | 79 | |
| 122 | 2.4B USD | 67 | 64 | |
| 122 | 21.5B DKK (≈$3.2B) | 67 | 58 | |
| 122 | 15.7B SEK (≈$1.6B) | 67 | 51 | |
| 122 | 2.2B USD | 67 | 66 | |
| 127 | 9.3B CNY (≈$1.3B) | 66 | 56 | |
| 127 | 8.3B CNY (≈$1.2B) | 66 | 66 | |
| 127 | 1.7B USD | 66 | 30 | |
| 127 | 1.7B USD | 66 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score